Description
Features & Benefits
BioGaia® Gastrus contains Limosilactobacillus reuteri DSM 17938 + Limosilactobacillus reuteri ATCC PTA 6475, sourced from human origin.
Targeted support with this unique Limosilactobacillus reuteri strain combination.
- Contains only probiotic strains of human origin: Lactobacillus reuteri DSM 17938 + Lactobacillus reuteri ATCC PTA 6475 (both strains isolated from breast milk)
- Delivers probiotic strains that survive transit through gastrointestinal (GI) tract without significant loss of potency (CFUs)
- Contains two probiotic strains shown to colonise the GI tract and adhere strongly to mucosal layer
- Delivers a daily dose of 200 million organisms (CFUs) in a convenient one-a-day dose
- Does not require refrigeration, for ease of use and convenience.
Ingredients
Each BioGaia® Gastrus chewable tablet contains:
| Lactobacillus reuteri (DSM 17938) | 350 mg (100 million organisms) |
| Lactobacillus reuteri (ATCC PTA 6475) | 350 mg (100 million organisms) |
Warnings
Use only as directed and if symptoms persist consult your health professional. For practitioner dispensing only.